---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-074467"
form_type: "8-K"
ticker: "BGMS"
cik: "0001130166"
company_name: "Bio Green Med Solution, Inc."
filed_at: "2024-06-25T23:59:59+00:00"
generated_at: "2026-06-01T02:06:07.744509+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cyclacel suspends preferred stock dividend; replaces Board Chair, defers CEO salary

## Summary
- Suspended quarterly cash dividend on 6% Convertible Exchangeable Preferred Stock (CYCCP) scheduled for Aug 1, 2024; board will evaluate quarterly.
- Dr. Samuel L. Barker appointed Chair of board; Dr. Christopher Henney stepped down as Chair but remains director.
- CEO Spiro Rombotis agreed to defer $22,000/month of salary until Dec 31, 2024; amount forfeited if not paid by then.
- Stockholders approved amendment to 2018 Equity Incentive Plan, reserving additional 160,000 shares of common stock.
- All three Class 3 director nominees (Henney, McBarron, Spiegel) re-elected; RSM US LLP ratified as auditor.

## SEC filing metadata
- accession: 0001104659-24-074467
- form_type: 8-K
- ticker: BGMS
- cik: 0001130166
- company_name: Bio Green Med Solution, Inc.
- filed_at: 2024-06-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130166/000110465924074467/0001104659-24-074467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130166/000110465924074467/tm2418092d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-074467
- JSON: https://secwatch.observer/filing/0001104659-24-074467.json
- Plain text: https://secwatch.observer/filing/0001104659-24-074467.txt

## Key facts
- Executive change
  Dr. Samuel L. Barker was appointed as Chair of the board at Bio Green Med Solution, Inc..
  - Action: appointed
  - Role: Chair of the board
  source text: Effective June 21, 2024, by resolution of the board of directors of the Company, Dr. Samuel L. Barker was appointed Chair of the board of directors to replace Dr. Christopher Henney, who requested to step down as Chair but will continue as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1130166/000110465924074467/0001104659-24-074467-index.htm
- Executive change
  Dr. Christopher Henney changed role as Director at Bio Green Med Solution, Inc..
  - Action: stepped down as Chair
  - Role: Director
  source text: Effective June 21, 2024, by resolution of the board of directors of the Company, Dr. Samuel L. Barker was appointed Chair of the board of directors to replace Dr. Christopher Henney, who requested to step down as Chair but will continue as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1130166/000110465924074467/0001104659-24-074467-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.